Capital Wealth Alliance’s CapForce IBD 50 ETF FFTY Stock Holding History

Capital Wealth Alliance’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,200	Closed	-$43K	–	168
2019 Q4	$43K	Buy	+1,200	New	+$40.6K	0.04%	150

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Capital Wealth Alliance's FFTY Position: Q1 2020 in Review

Capital Wealth Alliance sold out of CapForce IBD 50 ETF (FFTY) in Q1 2020, closing a stake of 1,200 shares — an estimated $43K sold.

Capital Wealth Alliance first reported a position in FFTY in Q4 2019 and held it in 1 quarter. The position peaked at $43K in Q4 2019. 67 funds tracked by Wall St. Rank hold FFTY as of Q1 2020.

Capital Wealth Alliance reported no remaining CapForce IBD 50 ETF position as of Q1 2020 after selling out during the quarter.
Capital Wealth Alliance sold 1,200 CapForce IBD 50 ETF shares in Q1 2020, an estimated $43K.
Capital Wealth Alliance first reported a position in CapForce IBD 50 ETF in Q4 2019 and held it in 1 quarter.
Capital Wealth Alliance's CapForce IBD 50 ETF position peaked at $43K in Q4 2019.
67 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.